Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study
Abstract Background Gliomas consist of a heterogeneous group of tumors. This study aimed to report the incidences of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, 1p19q co-deletion, isocitrate dehydrogenase (IDH) gene mutations, and inactivating mutations of alpha-thalassemia/m...
Main Authors: | Samantha Ya Lyn Ang, Lester Lee, Angela An Qi See, Ting Yao Ang, Beng Ti Ang, Nicolas Kon Kam King |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-020-6536-x |
Similar Items
-
The Role of ATRX in Glioma Biology
by: Pravanya Nandakumar, et al.
Published: (2017-09-01) -
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
by: Ralph Salloum, et al.
Published: (2017-10-01) -
Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions
by: Krzysztof Roszkowski, et al.
Published: (2016-11-01) -
Assessing Versatile Machine Learning Models for Glioma Radiogenomic Studies across Hospitals
by: Risa K. Kawaguchi, et al.
Published: (2021-07-01) -
Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01)